 | • レポートコード：MRC2Q12-16751 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、127ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、臨床体外診断技術のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 臨床体外診断技術のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 臨床体外診断技術の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 臨床体外診断技術のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの臨床体外診断技術の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の臨床体外診断技術の売上および2028年までの予測に焦点を当てています。 臨床体外診断技術のグローバル主要企業には、Acibadem Labmed、ACM Medical Laboratory、American Bio-Clinical Laboratories、American Pathology Partners、ARUP Laboratories、Bio-Reference Laboratories、Bioscientia、BP Healthcare Group、Clongen Laboratories、CompuNet、Eurofins Scientific、Exagen、Innoquest Pathology、Lifelabs、Mayo Clinic Laboratories、NeoGenomics、OncoDNA、ProPhase Labs、Psychemedics、Quest Diagnostics、RDL Reference Laboratory、Sonic Healthcare、Spectra Laboratories、Sysmex Inostics、Unilabsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 臨床体外診断技術市場は、タイプとアプリケーションによって区分されます。世界の臨床体外診断技術市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 生化学診断学、免疫診断学、分子診断学、微生物診断学、その他 【アプリケーション別セグメント】 総合病院、専門クリニック 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 臨床体外診断技術製品概要 - タイプ別市場（生化学診断学、免疫診断学、分子診断学、微生物診断学、その他） - アプリケーション別市場（総合病院、専門クリニック） - 調査の目的 ・エグゼクティブサマリー - 世界の臨床体外診断技術販売量予測2017-2028 - 世界の臨床体外診断技術売上予測2017-2028 - 臨床体外診断技術の地域別販売量 - 臨床体外診断技術の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別臨床体外診断技術販売量 - 主要メーカー別臨床体外診断技術売上 - 主要メーカー別臨床体外診断技術価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（生化学診断学、免疫診断学、分子診断学、微生物診断学、その他） - 臨床体外診断技術のタイプ別販売量 - 臨床体外診断技術のタイプ別売上 - 臨床体外診断技術のタイプ別価格 ・アプリケーション別市場規模（総合病院、専門クリニック） - 臨床体外診断技術のアプリケーション別販売量 - 臨床体外診断技術のアプリケーション別売上 - 臨床体外診断技術のアプリケーション別価格 ・北米市場 - 北米の臨床体外診断技術市場規模（タイプ別、アプリケーション別） - 主要国別の臨床体外診断技術市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの臨床体外診断技術市場規模（タイプ別、アプリケーション別） - 主要国別の臨床体外診断技術市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の臨床体外診断技術市場規模（タイプ別、アプリケーション別） - 主要国別の臨床体外診断技術市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の臨床体外診断技術市場規模（タイプ別、アプリケーション別） - 主要国別の臨床体外診断技術市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの臨床体外診断技術市場規模（タイプ別、アプリケーション別） - 主要国別の臨床体外診断技術市場規模（トルコ、サウジアラビア） ・企業情報 Acibadem Labmed、ACM Medical Laboratory、American Bio-Clinical Laboratories、American Pathology Partners、ARUP Laboratories、Bio-Reference Laboratories、Bioscientia、BP Healthcare Group、Clongen Laboratories、CompuNet、Eurofins Scientific、Exagen、Innoquest Pathology、Lifelabs、Mayo Clinic Laboratories、NeoGenomics、OncoDNA、ProPhase Labs、Psychemedics、Quest Diagnostics、RDL Reference Laboratory、Sonic Healthcare、Spectra Laboratories、Sysmex Inostics、Unilabs ・産業チェーン及び販売チャネル分析 - 臨床体外診断技術の産業チェーン分析 - 臨床体外診断技術の原材料 - 臨床体外診断技術の生産プロセス - 臨床体外診断技術の販売及びマーケティング - 臨床体外診断技術の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 臨床体外診断技術の産業動向 - 臨床体外診断技術のマーケットドライバー - 臨床体外診断技術の課題 - 臨床体外診断技術の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Clinical in Vitro Diagnostic Technique estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Clinical in Vitro Diagnostic Technique is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Clinical in Vitro Diagnostic Technique is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Clinical in Vitro Diagnostic Technique is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Clinical in Vitro Diagnostic Technique include Acibadem Labmed, ACM Medical Laboratory, American Bio-Clinical Laboratories, American Pathology Partners, ARUP Laboratories, Bio-Reference Laboratories, Bioscientia, BP Healthcare Group and Clongen Laboratories, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Clinical in Vitro Diagnostic Technique companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Clinical in Vitro Diagnostic Technique market. Further, it explains the major drivers and regional dynamics of the global Clinical in Vitro Diagnostic Technique market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Acibadem Labmed
ACM Medical Laboratory
American Bio-Clinical Laboratories
American Pathology Partners
ARUP Laboratories
Bio-Reference Laboratories
Bioscientia
BP Healthcare Group
Clongen Laboratories
CompuNet
Eurofins Scientific
Exagen
Innoquest Pathology
Lifelabs
Mayo Clinic Laboratories
NeoGenomics
OncoDNA
ProPhase Labs
Psychemedics
Quest Diagnostics
RDL Reference Laboratory
Sonic Healthcare
Spectra Laboratories
Sysmex Inostics
Unilabs
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Clinical in Vitro Diagnostic Technique Segment by Type
Biochemical Diagnostics
ImmunoDiagnostics
Molecular Diagnostics
Microbiological Diagnostics
Others
Clinical in Vitro Diagnostic Technique Segment by Application
General Hospitals
Specialty Clinics
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Clinical in Vitro Diagnostic Technique market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Clinical in Vitro Diagnostic Technique market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Clinical in Vitro Diagnostic Technique, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Clinical in Vitro Diagnostic Technique, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Clinical in Vitro Diagnostic Technique revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Clinical in Vitro Diagnostic Technique market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Clinical in Vitro Diagnostic Technique revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Acibadem Labmed, ACM Medical Laboratory, American Bio-Clinical Laboratories, American Pathology Partners, ARUP Laboratories, Bio-Reference Laboratories, Bioscientia, BP Healthcare Group and Clongen Laboratories, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Clinical in Vitro Diagnostic Technique in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical in Vitro Diagnostic Technique companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Clinical in Vitro Diagnostic Technique revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical in Vitro Diagnostic Technique Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Biochemical Diagnostics
1.2.3 ImmunoDiagnostics
1.2.4 Molecular Diagnostics
1.2.5 Microbiological Diagnostics
1.2.6 Others
1.3 Market by Application
1.3.1 Global Clinical in Vitro Diagnostic Technique Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 General Hospitals
1.3.3 Specialty Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Clinical in Vitro Diagnostic Technique Market Perspective (2017-2028)
2.2 Clinical in Vitro Diagnostic Technique Growth Trends by Region
2.2.1 Clinical in Vitro Diagnostic Technique Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Clinical in Vitro Diagnostic Technique Historic Market Size by Region (2017-2022)
2.2.3 Clinical in Vitro Diagnostic Technique Forecasted Market Size by Region (2023-2028)
2.3 Clinical in Vitro Diagnostic Technique Market Dynamics
2.3.1 Clinical in Vitro Diagnostic Technique Industry Trends
2.3.2 Clinical in Vitro Diagnostic Technique Market Drivers
2.3.3 Clinical in Vitro Diagnostic Technique Market Challenges
2.3.4 Clinical in Vitro Diagnostic Technique Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical in Vitro Diagnostic Technique Players by Revenue
3.1.1 Global Top Clinical in Vitro Diagnostic Technique Players by Revenue (2017-2022)
3.1.2 Global Clinical in Vitro Diagnostic Technique Revenue Market Share by Players (2017-2022)
3.2 Global Clinical in Vitro Diagnostic Technique Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Clinical in Vitro Diagnostic Technique Revenue
3.4 Global Clinical in Vitro Diagnostic Technique Market Concentration Ratio
3.4.1 Global Clinical in Vitro Diagnostic Technique Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical in Vitro Diagnostic Technique Revenue in 2021
3.5 Clinical in Vitro Diagnostic Technique Key Players Head office and Area Served
3.6 Key Players Clinical in Vitro Diagnostic Technique Product Solution and Service
3.7 Date of Enter into Clinical in Vitro Diagnostic Technique Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical in Vitro Diagnostic Technique Breakdown Data by Type
4.1 Global Clinical in Vitro Diagnostic Technique Historic Market Size by Type (2017-2022)
4.2 Global Clinical in Vitro Diagnostic Technique Forecasted Market Size by Type (2023-2028)
5 Clinical in Vitro Diagnostic Technique Breakdown Data by Application
5.1 Global Clinical in Vitro Diagnostic Technique Historic Market Size by Application (2017-2022)
5.2 Global Clinical in Vitro Diagnostic Technique Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Clinical in Vitro Diagnostic Technique Market Size (2017-2028)
6.2 North America Clinical in Vitro Diagnostic Technique Market Size by Type
6.2.1 North America Clinical in Vitro Diagnostic Technique Market Size by Type (2017-2022)
6.2.2 North America Clinical in Vitro Diagnostic Technique Market Size by Type (2023-2028)
6.2.3 North America Clinical in Vitro Diagnostic Technique Market Share by Type (2017-2028)
6.3 North America Clinical in Vitro Diagnostic Technique Market Size by Application
6.3.1 North America Clinical in Vitro Diagnostic Technique Market Size by Application (2017-2022)
6.3.2 North America Clinical in Vitro Diagnostic Technique Market Size by Application (2023-2028)
6.3.3 North America Clinical in Vitro Diagnostic Technique Market Share by Application (2017-2028)
6.4 North America Clinical in Vitro Diagnostic Technique Market Size by Country
6.4.1 North America Clinical in Vitro Diagnostic Technique Market Size by Country (2017-2022)
6.4.2 North America Clinical in Vitro Diagnostic Technique Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Clinical in Vitro Diagnostic Technique Market Size (2017-2028)
7.2 Europe Clinical in Vitro Diagnostic Technique Market Size by Type
7.2.1 Europe Clinical in Vitro Diagnostic Technique Market Size by Type (2017-2022)
7.2.2 Europe Clinical in Vitro Diagnostic Technique Market Size by Type (2023-2028)
7.2.3 Europe Clinical in Vitro Diagnostic Technique Market Share by Type (2017-2028)
7.3 Europe Clinical in Vitro Diagnostic Technique Market Size by Application
7.3.1 Europe Clinical in Vitro Diagnostic Technique Market Size by Application (2017-2022)
7.3.2 Europe Clinical in Vitro Diagnostic Technique Market Size by Application (2023-2028)
7.3.3 Europe Clinical in Vitro Diagnostic Technique Market Share by Application (2017-2028)
7.4 Europe Clinical in Vitro Diagnostic Technique Market Size by Country
7.4.1 Europe Clinical in Vitro Diagnostic Technique Market Size by Country (2017-2022)
7.4.2 Europe Clinical in Vitro Diagnostic Technique Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical in Vitro Diagnostic Technique Market Size (2017-2028)
8.2 Asia-Pacific Clinical in Vitro Diagnostic Technique Market Size by Type
8.2.1 Asia-Pacific Clinical in Vitro Diagnostic Technique Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Clinical in Vitro Diagnostic Technique Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Clinical in Vitro Diagnostic Technique Market Share by Type (2017-2028)
8.3 Asia-Pacific Clinical in Vitro Diagnostic Technique Market Size by Application
8.3.1 Asia-Pacific Clinical in Vitro Diagnostic Technique Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Clinical in Vitro Diagnostic Technique Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Clinical in Vitro Diagnostic Technique Market Share by Application (2017-2028)
8.4 Asia-Pacific Clinical in Vitro Diagnostic Technique Market Size by Region
8.4.1 Asia-Pacific Clinical in Vitro Diagnostic Technique Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Clinical in Vitro Diagnostic Technique Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Clinical in Vitro Diagnostic Technique Market Size (2017-2028)
9.2 Latin America Clinical in Vitro Diagnostic Technique Market Size by Type
9.2.1 Latin America Clinical in Vitro Diagnostic Technique Market Size by Type (2017-2022)
9.2.2 Latin America Clinical in Vitro Diagnostic Technique Market Size by Type (2023-2028)
9.2.3 Latin America Clinical in Vitro Diagnostic Technique Market Share by Type (2017-2028)
9.3 Latin America Clinical in Vitro Diagnostic Technique Market Size by Application
9.3.1 Latin America Clinical in Vitro Diagnostic Technique Market Size by Application (2017-2022)
9.3.2 Latin America Clinical in Vitro Diagnostic Technique Market Size by Application (2023-2028)
9.3.3 Latin America Clinical in Vitro Diagnostic Technique Market Share by Application (2017-2028)
9.4 Latin America Clinical in Vitro Diagnostic Technique Market Size by Country
9.4.1 Latin America Clinical in Vitro Diagnostic Technique Market Size by Country (2017-2022)
9.4.2 Latin America Clinical in Vitro Diagnostic Technique Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical in Vitro Diagnostic Technique Market Size (2017-2028)
10.2 Middle East & Africa Clinical in Vitro Diagnostic Technique Market Size by Type
10.2.1 Middle East & Africa Clinical in Vitro Diagnostic Technique Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Clinical in Vitro Diagnostic Technique Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Clinical in Vitro Diagnostic Technique Market Share by Type (2017-2028)
10.3 Middle East & Africa Clinical in Vitro Diagnostic Technique Market Size by Application
10.3.1 Middle East & Africa Clinical in Vitro Diagnostic Technique Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Clinical in Vitro Diagnostic Technique Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Clinical in Vitro Diagnostic Technique Market Share by Application (2017-2028)
10.4 Middle East & Africa Clinical in Vitro Diagnostic Technique Market Size by Country
10.4.1 Middle East & Africa Clinical in Vitro Diagnostic Technique Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Clinical in Vitro Diagnostic Technique Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Acibadem Labmed
11.1.1 Acibadem Labmed Company Details
11.1.2 Acibadem Labmed Business Overview
11.1.3 Acibadem Labmed Clinical in Vitro Diagnostic Technique Introduction
11.1.4 Acibadem Labmed Revenue in Clinical in Vitro Diagnostic Technique Business (2017-2022)
11.1.5 Acibadem Labmed Recent Developments
11.2 ACM Medical Laboratory
11.2.1 ACM Medical Laboratory Company Details
11.2.2 ACM Medical Laboratory Business Overview
11.2.3 ACM Medical Laboratory Clinical in Vitro Diagnostic Technique Introduction
11.2.4 ACM Medical Laboratory Revenue in Clinical in Vitro Diagnostic Technique Business (2017-2022)
11.2.5 ACM Medical Laboratory Recent Developments
11.3 American Bio-Clinical Laboratories
11.3.1 American Bio-Clinical Laboratories Company Details
11.3.2 American Bio-Clinical Laboratories Business Overview
11.3.3 American Bio-Clinical Laboratories Clinical in Vitro Diagnostic Technique Introduction
11.3.4 American Bio-Clinical Laboratories Revenue in Clinical in Vitro Diagnostic Technique Business (2017-2022)
11.3.5 American Bio-Clinical Laboratories Recent Developments
11.4 American Pathology Partners
11.4.1 American Pathology Partners Company Details
11.4.2 American Pathology Partners Business Overview
11.4.3 American Pathology Partners Clinical in Vitro Diagnostic Technique Introduction
11.4.4 American Pathology Partners Revenue in Clinical in Vitro Diagnostic Technique Business (2017-2022)
11.4.5 American Pathology Partners Recent Developments
11.5 ARUP Laboratories
11.5.1 ARUP Laboratories Company Details
11.5.2 ARUP Laboratories Business Overview
11.5.3 ARUP Laboratories Clinical in Vitro Diagnostic Technique Introduction
11.5.4 ARUP Laboratories Revenue in Clinical in Vitro Diagnostic Technique Business (2017-2022)
11.5.5 ARUP Laboratories Recent Developments
11.6 Bio-Reference Laboratories
11.6.1 Bio-Reference Laboratories Company Details
11.6.2 Bio-Reference Laboratories Business Overview
11.6.3 Bio-Reference Laboratories Clinical in Vitro Diagnostic Technique Introduction
11.6.4 Bio-Reference Laboratories Revenue in Clinical in Vitro Diagnostic Technique Business (2017-2022)
11.6.5 Bio-Reference Laboratories Recent Developments
11.7 Bioscientia
11.7.1 Bioscientia Company Details
11.7.2 Bioscientia Business Overview
11.7.3 Bioscientia Clinical in Vitro Diagnostic Technique Introduction
11.7.4 Bioscientia Revenue in Clinical in Vitro Diagnostic Technique Business (2017-2022)
11.7.5 Bioscientia Recent Developments
11.8 BP Healthcare Group
11.8.1 BP Healthcare Group Company Details
11.8.2 BP Healthcare Group Business Overview
11.8.3 BP Healthcare Group Clinical in Vitro Diagnostic Technique Introduction
11.8.4 BP Healthcare Group Revenue in Clinical in Vitro Diagnostic Technique Business (2017-2022)
11.8.5 BP Healthcare Group Recent Developments
11.9 Clongen Laboratories
11.9.1 Clongen Laboratories Company Details
11.9.2 Clongen Laboratories Business Overview
11.9.3 Clongen Laboratories Clinical in Vitro Diagnostic Technique Introduction
11.9.4 Clongen Laboratories Revenue in Clinical in Vitro Diagnostic Technique Business (2017-2022)
11.9.5 Clongen Laboratories Recent Developments
11.10 CompuNet
11.10.1 CompuNet Company Details
11.10.2 CompuNet Business Overview
11.10.3 CompuNet Clinical in Vitro Diagnostic Technique Introduction
11.10.4 CompuNet Revenue in Clinical in Vitro Diagnostic Technique Business (2017-2022)
11.10.5 CompuNet Recent Developments
11.11 Eurofins Scientific
11.11.1 Eurofins Scientific Company Details
11.11.2 Eurofins Scientific Business Overview
11.11.3 Eurofins Scientific Clinical in Vitro Diagnostic Technique Introduction
11.11.4 Eurofins Scientific Revenue in Clinical in Vitro Diagnostic Technique Business (2017-2022)
11.11.5 Eurofins Scientific Recent Developments
11.12 Exagen
11.12.1 Exagen Company Details
11.12.2 Exagen Business Overview
11.12.3 Exagen Clinical in Vitro Diagnostic Technique Introduction
11.12.4 Exagen Revenue in Clinical in Vitro Diagnostic Technique Business (2017-2022)
11.12.5 Exagen Recent Developments
11.13 Innoquest Pathology
11.13.1 Innoquest Pathology Company Details
11.13.2 Innoquest Pathology Business Overview
11.13.3 Innoquest Pathology Clinical in Vitro Diagnostic Technique Introduction
11.13.4 Innoquest Pathology Revenue in Clinical in Vitro Diagnostic Technique Business (2017-2022)
11.13.5 Innoquest Pathology Recent Developments
11.14 Lifelabs
11.14.1 Lifelabs Company Details
11.14.2 Lifelabs Business Overview
11.14.3 Lifelabs Clinical in Vitro Diagnostic Technique Introduction
11.14.4 Lifelabs Revenue in Clinical in Vitro Diagnostic Technique Business (2017-2022)
11.14.5 Lifelabs Recent Developments
11.15 Mayo Clinic Laboratories
11.15.1 Mayo Clinic Laboratories Company Details
11.15.2 Mayo Clinic Laboratories Business Overview
11.15.3 Mayo Clinic Laboratories Clinical in Vitro Diagnostic Technique Introduction
11.15.4 Mayo Clinic Laboratories Revenue in Clinical in Vitro Diagnostic Technique Business (2017-2022)
11.15.5 Mayo Clinic Laboratories Recent Developments
11.16 NeoGenomics
11.16.1 NeoGenomics Company Details
11.16.2 NeoGenomics Business Overview
11.16.3 NeoGenomics Clinical in Vitro Diagnostic Technique Introduction
11.16.4 NeoGenomics Revenue in Clinical in Vitro Diagnostic Technique Business (2017-2022)
11.16.5 NeoGenomics Recent Developments
11.17 OncoDNA
11.17.1 OncoDNA Company Details
11.17.2 OncoDNA Business Overview
11.17.3 OncoDNA Clinical in Vitro Diagnostic Technique Introduction
11.17.4 OncoDNA Revenue in Clinical in Vitro Diagnostic Technique Business (2017-2022)
11.17.5 OncoDNA Recent Developments
11.18 ProPhase Labs
11.18.1 ProPhase Labs Company Details
11.18.2 ProPhase Labs Business Overview
11.18.3 ProPhase Labs Clinical in Vitro Diagnostic Technique Introduction
11.18.4 ProPhase Labs Revenue in Clinical in Vitro Diagnostic Technique Business (2017-2022)
11.18.5 ProPhase Labs Recent Developments
11.19 Psychemedics
11.19.1 Psychemedics Company Details
11.19.2 Psychemedics Business Overview
11.19.3 Psychemedics Clinical in Vitro Diagnostic Technique Introduction
11.19.4 Psychemedics Revenue in Clinical in Vitro Diagnostic Technique Business (2017-2022)
11.19.5 Psychemedics Recent Developments
11.20 Quest Diagnostics
11.20.1 Quest Diagnostics Company Details
11.20.2 Quest Diagnostics Business Overview
11.20.3 Quest Diagnostics Clinical in Vitro Diagnostic Technique Introduction
11.20.4 Quest Diagnostics Revenue in Clinical in Vitro Diagnostic Technique Business (2017-2022)
11.20.5 Quest Diagnostics Recent Developments
11.21 RDL Reference Laboratory
11.21.1 RDL Reference Laboratory Company Details
11.21.2 RDL Reference Laboratory Business Overview
11.21.3 RDL Reference Laboratory Clinical in Vitro Diagnostic Technique Introduction
11.21.4 RDL Reference Laboratory Revenue in Clinical in Vitro Diagnostic Technique Business (2017-2022)
11.21.5 RDL Reference Laboratory Recent Developments
11.22 Sonic Healthcare
11.22.1 Sonic Healthcare Company Details
11.22.2 Sonic Healthcare Business Overview
11.22.3 Sonic Healthcare Clinical in Vitro Diagnostic Technique Introduction
11.22.4 Sonic Healthcare Revenue in Clinical in Vitro Diagnostic Technique Business (2017-2022)
11.22.5 Sonic Healthcare Recent Developments
11.23 Spectra Laboratories
11.23.1 Spectra Laboratories Company Details
11.23.2 Spectra Laboratories Business Overview
11.23.3 Spectra Laboratories Clinical in Vitro Diagnostic Technique Introduction
11.23.4 Spectra Laboratories Revenue in Clinical in Vitro Diagnostic Technique Business (2017-2022)
11.23.5 Spectra Laboratories Recent Developments
11.24 Sysmex Inostics
11.24.1 Sysmex Inostics Company Details
11.24.2 Sysmex Inostics Business Overview
11.24.3 Sysmex Inostics Clinical in Vitro Diagnostic Technique Introduction
11.24.4 Sysmex Inostics Revenue in Clinical in Vitro Diagnostic Technique Business (2017-2022)
11.24.5 Sysmex Inostics Recent Developments
11.25 Unilabs
11.25.1 Unilabs Company Details
11.25.2 Unilabs Business Overview
11.25.3 Unilabs Clinical in Vitro Diagnostic Technique Introduction
11.25.4 Unilabs Revenue in Clinical in Vitro Diagnostic Technique Business (2017-2022)
11.25.5 Unilabs Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer